Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University Children's Hospital Basel | OTHER |
| Insel Gruppe AG, University Hospital Bern | OTHER |
| University of Lausanne Hospitals | OTHER |
| Ente Ospedaliero Cantonale, Bellinzona |
Not provided
Not provided
Not provided
Not provided
The Swiss Patient Registry for DMD/BMD and SMA was launched in 2008 in order to give Swiss patients access to new therapies. It was founded with the financial support of several patient organizations and research foundations. Since 2008, children, adolescents and adults with DMD, BMD and SMA are registered with the help of all major muscle centers in Switzerland. After nearly ten years of activity, the Swiss Patient Registry for DMD/BMD and SMA implemented several adaptations in 2018 to meet current and future expectations of patient's organizations, health authorities and research organizations.
Background:
The 'Swiss registry for neuromuscular disorders' (Swiss-Reg-NMD) collects medical information from people with neuromuscular disorders. It is led by specialized physicians from all over Switzerland and located at the Institute of Social and Preventive Medicine (ISPM) in Bern. The registry includes children and adults living or treated in Switzerland who are diagnosed with Duchenne-Becker Muscular Dystrophy (DMD/BMD), Spinal Muscular Atrophy (SMA), merosin-deficient muscular dystrophy also called LAMA2-related muscular dystrophy (MDC1A respectively LAMA2) ) and Collagen 6 related muscular dystrophy.
The Swiss Registry for neuromuscular disorders was initially founded in 2008 to give Swiss patients with a neuromuscular disease access to new therapies. In 2018, the registry was reorganized to meet new legal requirements and expectations of patients and research organizations. The Swiss Ethics Commission approved the project (project ID: 2018-00289, observational study, risk category A).
NMDs are rare diseases with few patients scattered across the country. A national patient registry with a centralized registration facilitates the participation of Swiss patients in therapeutic trials and the creation of Swiss trial sites.
Objectives:
Primary objectives of the Swiss-Reg-NMD project are:
Establish a representative population-based Swiss cohort of children, adolescents and adults with NMDs
Provide epidemiological data to investigate the incidence, prevalence, spectrum of diagnosis, survival rates and mortality of NMDs in Switzerland
Provide a platform for clinical research:
Provide a platform for communication:
Inclusion/exclusion criteria:
All children, adolescents and adults living or treated in Switzerland who are diagnosed with a NMD. The diagnosis needs to be confirmed, whenever possible, by genetic testing, or at least by biopsy and/or electroneuromyography, according to international standards for the diagnosis of the given NMD. Once the diagnosis is established, there is no specific exclusion criteria.
Currently, patients with SMA, DMD/BMD, merosin-deficient muscular dystrophy also called LAMA2-related muscular dystrophy (MDC1A respectively LAMA2) and Collagen 6 related muscular dystrophy are included.
Procedure:
After a NMD diagnosis, the treating physician informs the patient and the parents (if the patient is still a child) during a consultation in a clinic or practice in writing and orally about the Swiss-Reg-NMD. The patient/parents who wish to participate sign the consent form and the patient is registered in the Swiss-Reg-NMD. If the patient/parents do not wish to participate, only a minimal anonymous data set is recorded.
The following data will be collected:
Clinical data (report of new cases and follow-up reports): NMD subtype, severity, and associated conditions; Comorbidities; Medical care and medication; Therapies; (Serious) adverse events; Hospitalisations; Motor Function Assessments; Socio-demographic characteristics.
Questionnaire data: We will collect data through questionnaires with a focus on (but not exclusively):
Routine data and linkages: e.g. Federal Statistical Office (e.g. birth registry, cause of death statistics, hospital statistics); Swiss National Cohort (socioeconomic data, family information); other medical registries (e.g. rare disease registry); Communities of residence (vital status, date of death, address).
Funding:
Schweizerische Muskelgesellschaft; ASRIMM, Association Suisse Romande Intervenant contre les Maladies neuromusculaire; MGR, Associazione malattie genetiche rare della svizzera italiana; fsrmm, schweizerische stiftung fĂ¼r die erforschung der muskelkrankheiten; SMA Schweiz; Duchenne Schweiz; Amicus Therapeutics; Avexis; Biogen; ITF Pharma; Novartis; Pfizer, PTC Therapeutics; Roche; Sanofi; Sarepta.
Data protection:
Data generation, transmission, storage and analysis of health related personal data within this project will follow strictly the current Swiss legal requirements for data protection. Data analyses will always be done using pseudonymised datasets. Health related personal data captured during this project are strictly confidential. Project data shall be handled with uttermost discretion and only be accessible to authorized personnel. Direct access to source documents will be permitted for purposes of monitoring, audits or inspections. The data protection concept of ISPM ensures the secure handling of all sensitive data at ISPM and within Swiss-Reg-NMD. The Swiss-Reg-NMD team is responsible for the implementation and compliance with the confidentiality and data security measures.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patient population | Children, adolescents and adults diagnosed with a NMD (DMD/BMD/IMD; SMA; COL-6; LAMA-2) who are treated or living in Switzerland. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Personal data | Registering and updating patients personal data | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Initial symptoms | Initial symptoms | At diagnosis |
| Age at initial symptoms and diagnosis | Age at initial symptoms and diagnosis | At diagnosis |
| Family history | Other affected family members | At diagnosis |
| Investigations | Type of investigations for diagnosis | At diagnosis |
| Diagnosis | Mutation | At diagnosis |
| Change of living status | Date of death | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Change of living status II | Cause of death | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All individuals living or treated in Switzerland with a diagnosis of a NMD. Currently, Spinal muscular atrophy, Duchenne muscular dystrophy, Merosin negative congenital muscular dystrophy MDC1A and Collagen 6 related muscular dystrophy are included. In the future, patients with other NMDs (e.g. Charcot-Marie-Tooth neuropathy, Myotonic Dystrophy or rare myopathies) may also be included if it appears relevant to clinicians and researchers active in the field of NMDs, patient organisations, and public health representatives.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Claudia E Kuehni, Prof. MD | Contact | +41 (0)31 684 35 07 | swiss-reg-nmd.ispm@unibe.ch |
| Name | Affiliation | Role |
|---|---|---|
| Claudia E Kuehni, Prof. MD | Institute of Social and Preventive Medicine (ISPM), University of Bern | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cantonal Hospital Aarau | Recruiting | Aarau | Canton of Aargau | Switzerland |
Not provided
| Label | URL |
|---|---|
| Website of the registry | View source |
Not provided
Researchers who wish to develop a nested study need to submit a proposal to the Swiss-Reg-NMD and request permission. A concept sheet describing the planned analyses must be approved by the Swiss-Reg-NMD Steering Board. Nested studies might need separate ethics permission.
Not provided
Not provided
Not provided
Not provided
Not provided
| OTHER |
| University Children's Hospital, Zurich | OTHER |
| University Hospital, ZĂ¼rich | OTHER |
| SwissPedNet | OTHER |
Not provided
Not provided
Not provided
| Change in height | Registering height | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Change in weight | Registering weight | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Change in head circumference | Registering head circumference | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Change in motor development and motor functions | Registering motor development and function (motor function scales) | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Change in musculoskeletal system | Assessing change in musculoskeletal system over time | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| History of surgeries | Registering surgeries | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Change in cardiac function | Registering cardiac function | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Change in pulmonary function | Registering pulmonary function | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Change in nutritional habits | Registering feeding habits | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Change in cognition | Assessing mental ability using tests, including language | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Change in education | Registering type of education | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Change in therapies | Registering therapies | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Change in orthopaedic situation | Assessing use of orthopaedic resources | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Change in treatments | Registering treatments | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Change in side effects | Registering side effects of treatments | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Change in comorbidities | Registering comorbidities | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| History of hospitalizations | Registering hospitalizations | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Change in disease specific markers | Registering change in disease specific markers | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Change in epilepsy | Registering epilepsy | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| History of participation in clinical trials and research studies | Registering participation in current/past clinical trials and research studies | Baseline medical information, follow-up data collection at regular intervals (at diagnosis, then at least annually, up to 80 years) |
| Questionnaire data | Questionnaires focusing on specific research questions (Health-related questions, health behavior, medical equipment, treatments and therapies, quality of life, participation, social-economic factors, academic information, patient/caregiver reported outcomes, needs, concerns) | 0-80 years |
| Pediatric Institute of Southern Switzerland, Ospedale San Giovanni | Recruiting | Bellinzona | Canton Ticino | Switzerland |
|
| Neuro Centre of Italian Switzerland, Ospedale Regionale di Lugano | Recruiting | Lugano | Canton Ticino | Switzerland |
|
| University Hospital Lausanne CHUV, Children's Hospital | Recruiting | Lausanne | Vaude | Switzerland |
|
| University Hospital Lausanne CHUV | Recruiting | Lausanne | Vaude | Switzerland |
|
| University Children's Hospital Basel | Recruiting | Basel | Switzerland |
|
| University Hospital Basel | Recruiting | Basel | Switzerland |
|
| Inselspital Bern, Children's Hospital | Recruiting | Bern | Switzerland |
|
| Inselspital Bern | Recruiting | Bern | Switzerland |
|
| Institute of Social and Preventive Medicine (ISPM), University of Bern | Recruiting | Bern | Switzerland |
|
| University Hospitals of Geneva, Children's Hospital | Recruiting | Geneva | Switzerland |
|
| University Hospitals of Geneva | Recruiting | Geneva | Switzerland |
|
| Cantonal Hospital of Lucerne LUKS | Recruiting | Lucerne | Switzerland |
|
| Cantonal Hospital of Lucerne, LUKS | Recruiting | Lucerne | Switzerland |
|
| Private Practice Alpenquai | Recruiting | Lucerne | Switzerland |
|
| Cantonal Hospital of Eastern Switzerland | Recruiting | Sankt Gallen | Switzerland |
|
| Children's Hospital of Eastern Switzerland | Recruiting | Sankt Gallen | Switzerland |
|
| University Hospital Zuerich, Children's Hospital | Recruiting | Zurich | Switzerland |
|
| University Hospital Zuerich | Recruiting | Zurich | Switzerland |
|